Pharma Ag Novartis, 10% Owner at IDENIX PHARMACEUTICALS INC (IDIX), bought 50,530 shares at $5.11 ($206K) on 2011-11-22, disclosed to the SEC on 2011-11-22.
Open-market purchase of $206k IDIX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.41 | 11,236 | $27K | 13.1% |
| 2 | $2.95 | 6,476 | $19K | 9.3% |
| 3 | $3.17 | 1,146 | $4K | 1.8% |
| 4 | $3.79 | 140 | $531 | 0.3% |
| 5 | $4.70 | 20,228 | $95K | 46.1% |
| 6 | $5.11 | 2,107 |
| $11K |
| 5.2% |
| 7 | $5.46 | 9,197 | $50K | 24.3% |
| Total | $4.08 avg | 50,530 | $206K | 100% |
| Filing → |
| IDIX | BUY | 2011-12-09 | $115K | — | Filing → |
| IDIX | BUY | 2010-11-26 | $47K | — | Filing → |
| IDIX | BUY | 2010-09-16 | $91K | — | Filing → |